Vanda Pharmaceuticals, Inc. (VNDA)

8.28 +0.11 (+1.35%) USD  |  NASDAQ  |  Feb 25, 16:00
8.24 -0.04 (-0.48%) After-Hours: 04:15
More

Vanda Pharmaceuticals Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for VNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Axsome Therapeutics, Inc. Upgrade
AnaptysBio, Inc. Upgrade
SELLAS Life Sciences Group, Inc. --
Protagenic Therapeutics, Inc. --